Clinical Trial Update: Efficacy of Administration of Somatostatin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of somatostatin in preventing post-ERCP pancreatitis; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Somatostatin (somatostatin)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Acute Pancreatitis | Phase 3 | Status: UNKNOWN